SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-24-150375
Filing Date
2024-05-30
Accepted
2024-05-30 16:29:13
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 d806941ds3.htm S-3 329818
2 EX-4.4 d806941dex44.htm EX-4.4 30095
3 EX-4.5 d806941dex45.htm EX-4.5 256202
4 EX-5.1 d806941dex51.htm EX-5.1 26891
5 EX-23.1 d806941dex231.htm EX-23.1 1725
6 EX-FILING FEES d806941dexfilingfees.htm EX-FILING FEES 54364
7 GRAPHIC g806941g42w05.jpg GRAPHIC 73256
  Complete submission text file 0001193125-24-150375.txt   801266
Mailing Address 175 INNOVATION BOULEVARD WILMINGTON DE 19805
Business Address 175 INNOVATION BOULEVARD WILMINGTON DE 19805 (302) 467-1280
Prelude Therapeutics Inc (Filer) CIK: 0001678660 (see all company filings)

IRS No.: 811384762 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-279829 | Film No.: 241005852
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)